文献速递血栓与止血

获得性血友病A:证据更新综述与治疗指导

Acquired hemophilia A: Updated review of evidence and treatment guidance.
PubMed 文献 · Am J Hematol · 2017-06-05

获得性血友病A(AHA)由针对内源性凝血因子Ⅷ的自身抗体引起,常表现为自发性严重出血,多见于有合并症的老年患者,死亡风险高。北美止血与血栓研究学会支持的国际专家小组分析关键问题、复习文献并形成共识,更新现有指南,总结AHA管理推荐。

要点

  • AHA由针对因子Ⅷ的自身抗体引起,出血常为自发性和严重性。
  • AHA多见于有合并症的老年患者,死亡风险与合并症、出血或治疗并发症相关。
  • 治疗包括止血管理和清除抑制剂,管理具有挑战性,现有数据有限。

核心结论

  • AHA在真实临床实践中可能诊断不足和误诊。
  • 基于现有数据并结合专家小组临床经验,总结AHA管理推荐以更新现有指南。

研究设计与样本

  • 由北美止血与血栓研究学会支持的国际专家小组分析关键问题、复习文献、权衡证据并形成共识。

主要发现

  • AHA由针对内源性因子Ⅷ的自身抗体(抑制剂)引起,导致常为自发性和严重的出血。
  • AHA多发生于有合并症的老年患者,死亡风险高,与合并症、出血或治疗并发症相关。
  • 治疗包括止血管理和清除抑制剂,管理具有挑战性,指导AHA相关出血和清除致病抗体的数据有限。
  • AHA在真实临床实践中可能诊断不足和误诊。

局限性

  • 指导AHA相关出血管理和清除致病抗体的数据有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquired hemophilia A (AHA) is a rare disease resulting from autoantibodies (inhibitors) against endogenous factor VIII (FVIII) that leads to bleeding, which is often spontaneous and severe. AHA tends to occur in elderly patients with comorbidities and is associated with high mortality risk from underlying comorbidities, bleeding, or treatment complications. Treatment, which consists of hemostatic management and eradication of the inhibitors, can be challenging to manage. Few data are available to guide the management of AHA-related bleeding and eradication of the disease-causing antibodies. Endorsed by the Hemostasis and Thrombosis Research Society of North America, an international panel of experts in AHA analyzed key questions, reviewed the literature, weighed the evidence and formed a consensus to update existing guidelines. AHA is likely underdiagnosed and misdiagnosed in real-world clinical practice. Recommendations for the management of AHA are summarized here based on the available data, integrated with the clinical experience of panel participants.

来源:Am J Hematol,查看原文。版权归原作者所有。

引用

  1. Kruse-Jarres R, Kempton CL, Baudo F, et al. Acquired hemophilia A: Updated review of evidence and treatment guidance. Am J Hematol. 2017. PMID: 28470674. doi:10.1002/ajh.24777

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。